ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
09/02/2025
Back to search
Official data from USPTO
AMNEAL PHARMACEUTICALS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
46
Latest update
09/03/2025
Trademark type
Combined
Nice classes
5, 35, 42
Filing date
07/21/2011
Registration date
08/28/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/07/2023
Last transaction
09/03/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
2008-01-00
First use in commerce
2008-01-00
Drawing code
3
Owner type
16
Owner location
Bridgewater, NJ
Examiner
KON, ELISSA
Law office
L60
Current location
TMEG LAW OFFICE 106
Mark description
The mark consists of a leaping figure shape over the top left of the wording ''AMNEAL PHARMACUETICALS''.
Holders and representatives
Holders
Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals LLC
Representatives
Karen M. Whitney Servilla Whitney LLC
Technical classification
Nice Classes
Class 5Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Full line of prescription and over-the-counter pharmaceutical preparations for humans
Class 35
Pharmaceutical servicesprocessing orders for pharmacies and health care facilities and organizationsdistributorship services and business development in the field of prescription and over-the-counter pharmaceutical preparations for humans
Class 42
Research and product development for others in the field of prescription and over-the-counter pharmaceutical preparations for humans; product development for others of a wide variety of prescription and over-the-counter pharmaceutical preparations for humans
Publications
History of USPTO decisions and trademark events.
46 publications found
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
01/29/2025
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
08/07/2023
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/07/2023
9G8P
REGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8
08/07/2023
8PRT
REGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED
08/07/2023
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
06/27/2023
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
12/27/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/26/2022
E89R
TEAS SECTION 8 & 9 RECEIVED
06/09/2022
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
06/01/2022
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
08/28/2021
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/08/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/08/2019
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/18/2018
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
07/04/2018
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - MAILED
05/21/2018
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/21/2018
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
05/18/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/18/2018
E815
TEAS SECTION 8 & 15 RECEIVED
05/18/2018
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
04/25/2018
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/23/2018
ES7R
TEAS SECTION 7 REQUEST RECEIVED
03/26/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/26/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/28/2017
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
11/25/2015
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/28/2014
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/28/2014
R.PR
REGISTERED-PRINCIPAL REGISTER
08/28/2012
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/12/2012
PUBO
PUBLISHED FOR OPPOSITION
06/12/2012
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/23/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
05/08/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/04/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/03/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/03/2012
ALIE
ASSIGNED TO LIE
04/23/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/17/2012
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/11/2011
GNRT
NON-FINAL ACTION E-MAILED
11/11/2011
CNRT
NON-FINAL ACTION WRITTEN
11/11/2011
DOCK
ASSIGNED TO EXAMINER
11/10/2011
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
07/27/2011
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/26/2011
NWAP
NEW APPLICATION ENTERED
07/25/2011
Continuous trademark protection
Get notified about every new filing that threatens AMNEAL PHARMACEUTICALS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.